The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as:
· An extensive literature review, including coverage of research from fields other than marketing
· an overview of how practitioners have addressed the topic
· introduction of relevant analytical tools, such as statistics and ethnographic studies
· suggestions for further research by scholars and students
The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.
Edited by:
Min Ding, Jehoshua Eliashberg, Stefan Stremersch Imprint: Springer-Verlag New York Inc. Country of Publication: United States Edition: 2014 ed. Volume: 20 Dimensions:
Height: 235mm,
Width: 155mm,
Spine: 41mm
Weight: 1.445kg ISBN:9781461478003 ISBN 10: 1461478006 Series:International Series in Quantitative Marketing Pages: 768 Publication Date:14 November 2013 Audience:
Professional and scholarly
,
Undergraduate
Format:Hardback Publisher's Status: Active